Cancer Research Cancer Epigenetics  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 3311-3317, December 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayashi, M.
Right arrow Articles by Griffin, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashi, M.
Right arrow Articles by Griffin, A. C.

Purification and Properties of the Major Phenylalanyl Transfer RNA Species in Drug-resistant Ehrlich Tumor Cells1

Masao Hayashi2 and A. Clark Griffin3

Department of Biochemistry, The University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston, Texas 77025

Reverse-phase chromatography profiles of the tRNA's of normal mouse liver and also the Ehrlich ascites cells revealed the presence of three isoaccepting phenylalanyl transfer RNA (tRNAPhe) species. The first two peaks eluted from these columns, tRNAFormula and tRNAFormula, were small and were followed by a third and major peak designated tRNAFormula. Ehrlich tumor cells with an acquired resistance to nitrogen mustard, however, exhibited an altered chromatographic profile with minor tRNAFormula and tRNAFormula peaks and an exceptionally large tRNAFormula area. This tRNAFormula from the tumor cells as well as the major tRNAFormula from normal mouse liver was isolated and purified to 80% or higher. Coding properties, kinetic studies of aminoacylation, and the nucleoside composition of the tRNAPhe species were ascertained. The initial velocity of the aminoacylation reaction of the Ehrlich cell tRNAFormula was lower and the Km was slightly higher than the liver tRNAFormula. This provides some indication that the two transfer RNA's may have a different nucleotide sequence and/or modified bases in the recognition sites of the aminoacyl synthetases. RNase T1 digests of the two labeled tRNAPhe's with subsequent chromatography revealed that both may have the same nucleotide sequence from the 3'-terminal to the first guanosine residue. Other findings indicated similar codon responses, the appearance of 3'-methyl-cytidine, and an increase in 5'-methyl-cytidine and dihydrouracil in the predominant tRNAFormula of the resistant Ehrlich tumor cells.

1 Supported by grants from the American Cancer Society (P-550) and the Robert A. Welch Foundation (G-035).

2 Present address: Department of Biochemistry, Kurume University School of Medicine, Kurume, Japan 830.

3 To whom requests for reprints should be sent.

Received 3/20/74. Accepted 8/22/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.